Autoimmune inner ear disease

Diagnostic and therapeutic approaches in a multidisciplinary setting

Eric Lawrence Matteson, David A. Fabry, Scott E. Strome, Colin L W Driscoll, Charles W. Beatty, Thomas J. McDonald

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Autoimmune Inner Ear Disease (AIED) is a clinical syndrome of uncertain pathogenesis. It is associated with bilateral rapidly progressive hearing loss. The hearing loss may be associated with vestibular symptoms. Autoimmunity has been proposed as the pathogenesis of this sort of hearing loss, although the mechanism of the disease is poorly understood. It is well accepted that the endolymphatic sac is an immunocompetent organ and circulating autoantibodies against inner ear antigens have been reported, as have viral antigens in the endolymph, although the sensitivity, specificity, and roles of those antibodies in a disease process are poorly defined. We will describe the clinical aspects of the disease, the histopathology, the immunologic indicators, the types of presentation, both from the audiologic and vestibular point of view, clinical trials for treatment and the follow-up. One of our conclusions is that many of these patients respond favorably to the treatment Methotrexate.

Original languageEnglish (US)
Pages (from-to)225-230
Number of pages6
JournalJournal of the American Academy of Audiology
Volume14
Issue number4
StatePublished - Apr 2003

Fingerprint

Labyrinth Diseases
Hearing Loss
Endolymph
Endolymphatic Sac
Viral Antigens
Immune System Diseases
Inner Ear
Autoimmunity
Methotrexate
Autoantibodies
Therapeutics
Clinical Trials
Antigens
Sensitivity and Specificity
Antibodies

Keywords

  • Autoimmune inner ear disease
  • Methotrexate
  • PET Scan
  • Sensorineural hearing loss

ASJC Scopus subject areas

  • Speech and Hearing
  • Otorhinolaryngology

Cite this

Matteson, E. L., Fabry, D. A., Strome, S. E., Driscoll, C. L. W., Beatty, C. W., & McDonald, T. J. (2003). Autoimmune inner ear disease: Diagnostic and therapeutic approaches in a multidisciplinary setting. Journal of the American Academy of Audiology, 14(4), 225-230.

Autoimmune inner ear disease : Diagnostic and therapeutic approaches in a multidisciplinary setting. / Matteson, Eric Lawrence; Fabry, David A.; Strome, Scott E.; Driscoll, Colin L W; Beatty, Charles W.; McDonald, Thomas J.

In: Journal of the American Academy of Audiology, Vol. 14, No. 4, 04.2003, p. 225-230.

Research output: Contribution to journalArticle

Matteson, EL, Fabry, DA, Strome, SE, Driscoll, CLW, Beatty, CW & McDonald, TJ 2003, 'Autoimmune inner ear disease: Diagnostic and therapeutic approaches in a multidisciplinary setting', Journal of the American Academy of Audiology, vol. 14, no. 4, pp. 225-230.
Matteson, Eric Lawrence ; Fabry, David A. ; Strome, Scott E. ; Driscoll, Colin L W ; Beatty, Charles W. ; McDonald, Thomas J. / Autoimmune inner ear disease : Diagnostic and therapeutic approaches in a multidisciplinary setting. In: Journal of the American Academy of Audiology. 2003 ; Vol. 14, No. 4. pp. 225-230.
@article{8898a80af3ba4a8eb78b588efee8419d,
title = "Autoimmune inner ear disease: Diagnostic and therapeutic approaches in a multidisciplinary setting",
abstract = "Autoimmune Inner Ear Disease (AIED) is a clinical syndrome of uncertain pathogenesis. It is associated with bilateral rapidly progressive hearing loss. The hearing loss may be associated with vestibular symptoms. Autoimmunity has been proposed as the pathogenesis of this sort of hearing loss, although the mechanism of the disease is poorly understood. It is well accepted that the endolymphatic sac is an immunocompetent organ and circulating autoantibodies against inner ear antigens have been reported, as have viral antigens in the endolymph, although the sensitivity, specificity, and roles of those antibodies in a disease process are poorly defined. We will describe the clinical aspects of the disease, the histopathology, the immunologic indicators, the types of presentation, both from the audiologic and vestibular point of view, clinical trials for treatment and the follow-up. One of our conclusions is that many of these patients respond favorably to the treatment Methotrexate.",
keywords = "Autoimmune inner ear disease, Methotrexate, PET Scan, Sensorineural hearing loss",
author = "Matteson, {Eric Lawrence} and Fabry, {David A.} and Strome, {Scott E.} and Driscoll, {Colin L W} and Beatty, {Charles W.} and McDonald, {Thomas J.}",
year = "2003",
month = "4",
language = "English (US)",
volume = "14",
pages = "225--230",
journal = "Journal of the American Academy of Audiology",
issn = "1050-0545",
publisher = "American Academy of Audiology",
number = "4",

}

TY - JOUR

T1 - Autoimmune inner ear disease

T2 - Diagnostic and therapeutic approaches in a multidisciplinary setting

AU - Matteson, Eric Lawrence

AU - Fabry, David A.

AU - Strome, Scott E.

AU - Driscoll, Colin L W

AU - Beatty, Charles W.

AU - McDonald, Thomas J.

PY - 2003/4

Y1 - 2003/4

N2 - Autoimmune Inner Ear Disease (AIED) is a clinical syndrome of uncertain pathogenesis. It is associated with bilateral rapidly progressive hearing loss. The hearing loss may be associated with vestibular symptoms. Autoimmunity has been proposed as the pathogenesis of this sort of hearing loss, although the mechanism of the disease is poorly understood. It is well accepted that the endolymphatic sac is an immunocompetent organ and circulating autoantibodies against inner ear antigens have been reported, as have viral antigens in the endolymph, although the sensitivity, specificity, and roles of those antibodies in a disease process are poorly defined. We will describe the clinical aspects of the disease, the histopathology, the immunologic indicators, the types of presentation, both from the audiologic and vestibular point of view, clinical trials for treatment and the follow-up. One of our conclusions is that many of these patients respond favorably to the treatment Methotrexate.

AB - Autoimmune Inner Ear Disease (AIED) is a clinical syndrome of uncertain pathogenesis. It is associated with bilateral rapidly progressive hearing loss. The hearing loss may be associated with vestibular symptoms. Autoimmunity has been proposed as the pathogenesis of this sort of hearing loss, although the mechanism of the disease is poorly understood. It is well accepted that the endolymphatic sac is an immunocompetent organ and circulating autoantibodies against inner ear antigens have been reported, as have viral antigens in the endolymph, although the sensitivity, specificity, and roles of those antibodies in a disease process are poorly defined. We will describe the clinical aspects of the disease, the histopathology, the immunologic indicators, the types of presentation, both from the audiologic and vestibular point of view, clinical trials for treatment and the follow-up. One of our conclusions is that many of these patients respond favorably to the treatment Methotrexate.

KW - Autoimmune inner ear disease

KW - Methotrexate

KW - PET Scan

KW - Sensorineural hearing loss

UR - http://www.scopus.com/inward/record.url?scp=0642369624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642369624&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 225

EP - 230

JO - Journal of the American Academy of Audiology

JF - Journal of the American Academy of Audiology

SN - 1050-0545

IS - 4

ER -